ALFA Finder| Revenue growth | Flat sales performance indexed against comparable 12-month period. |
|---|---|
| Margins | PAT growth suggests margin expansion despite flat revenue. |
Growth
PAT increased by 19% YoY; Sales remained flat for the fiscal year 2025-26.
Outlook
Targeting INR 86 crores in productivity savings; focus on data platforms and AI for operational efficiency.
Risks
Identified headwinds include inflation, media transformation, and a changing retail landscape.
Last quarter's promises, checked
Delivered
- Guided consistent mid-single digit sales growth → delivered flat (= MISS)
- Guided 8% compounded profit growth → delivered 19% PAT growth (= BEAT)
- Guided Rs. 93 Cr productivity savings → delivered Rs. 86 Cr target for next year (= PARTIAL)
Partly delivered
- Guided productivity as fuel for growth → delivered margin expansion but failed to convert to revenue growth (= PARTIAL)
Missed
- Guided mid-single digit sales growth → delivered flat sales (= MISS)
Earnings Call filed with BSE, NSE: PGHH. Summary written with AI assistance from the document.
Procter & Gamble Hygiene & Healthcare Ltd: key numbers
- Share price
- ₹7,202.50
- Market cap
- ₹23,380 Cr
- Revenue (annual)
- ₹4,290 Cr
- Net profit (annual)
- ₹856.5 Cr
- P/E (TTM)
- 29.6×Sector 41.3×
- Promoter holding
- 70.64%+0.00% QoQ
- FII holding
- 0.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Procter & Gamble Hygiene & Healthcare Ltd
All →Procter & Gamble Hygiene & Healthcare Other Announcement
Procter & Gamble Hygiene and Health Care Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, with the exchange.
Procter & Gamble Hygiene & Healthcare Board Meeting Date
P&G Hygiene and Health Care will hold a board meeting on November 12, 2026, to consider unaudited standalone financial results for the half-year ending September 2026.
Procter & Gamble Hygiene & Healthcare Management Change
Procter & Gamble Hygiene and Health Care Limited has appointed Ms. Flavia Machado as Company Secretary and Compliance Officer, effective September 29, 2026.
Procter & Gamble Hygiene & Healthcare Price Movement Clarification
P&G Hygiene and Health Care denied baseless rumors of potential delisting or winding up. Filed under Reg 30(11) due to material price movement.
Procter & Gamble Hygiene & Healthcare Management Change
P&G Hygiene and Health Care announced appointment of Ms. Srividya Srinivasan as Whole-time Director effective July 1, 2026. Shareholders approved the five-year term at the 62nd AGM on September 8, 2026.
Procter & Gamble Hygiene & Healthcare Annual General Meeting
Procter & Gamble Hygiene and Health Care Ltd held its 62nd Annual General Meeting on September 8, 2026, to discuss financial statements, dividends, and director appointments.